tiprankstipranks
GoHealth (GOCOQ)
OTHER OTC:GOCOQ
US Market
Want to see GOCOQ full AI Analyst Report?

GoHealth (GOCOQ) AI Stock Analysis

508 Followers

Top Page

GOCOQ

GoHealth

(OTC:GOCOQ)

Select Model
Select Model
Select Model
Underperform 39 (OpenAI - 5.2)
Rating:39Underperform
Price Target:
$0.38
▼(-72.48% Downside)
Action:Reiterated
Date:06/17/26
The score is driven down primarily by very weak financial performance (sharp revenue decline, extreme losses, high leverage from near-depleted equity, and sizable cash burn) and significant bankruptcy/delisting corporate events that increase the risk of severe dilution or cancellation for common shareholders. Technicals are bearish (price below key moving averages) despite oversold signals, and valuation metrics provide limited support due to negative earnings and no dividend yield provided.
Positive Factors
Medicare-focused marketplace & agent network
GoHealth’s core business is a technology-enabled Medicare marketplace paired with an agent-assisted sales model. This durable distribution mix supports repeatable enrollment flows and scalable agent productivity, providing a structural channel advantage versus single-touch digital sellers.
Negative Factors
Sharp revenue contraction
A near-60% revenue decline and extreme net losses signal structural demand or execution issues that have eroded scale. Loss of scale undermines fixed-cost absorption, weakens agent economics, and makes restoring sustainable profitability more challenging absent material improvements to enrollment volumes or cost base.
Read all positive and negative factors
Positive Factors
Negative Factors
Medicare-focused marketplace & agent network
GoHealth’s core business is a technology-enabled Medicare marketplace paired with an agent-assisted sales model. This durable distribution mix supports repeatable enrollment flows and scalable agent productivity, providing a structural channel advantage versus single-touch digital sellers.
Read all positive factors

GoHealth (GOCOQ) vs. SPDR S&P 500 ETF (SPY)

GoHealth Business Overview & Revenue Model

Company Description
GoHealth, Inc. functions as a prominent digital health enterprise and health insurance marketplace operating across the United States, with a significant focus on Medicare products. Its business is strategically structured into four main divisions...
How the Company Makes Money
GoHealth primarily makes money by acting as a sales and distribution partner for health insurance carriers and earning commissions tied to successful enrollments. The company’s main revenue stream is carrier-paid commissions for Medicare-related e...

GoHealth Financial Statement Overview

Summary
Financials are severely weakened: TTM revenue is down ~58% with deeply negative profitability (net margin ~-190%), stockholders’ equity is nearly depleted (~$2.1M) driving very high leverage (debt-to-equity ~17.5x), and cash generation has turned materially negative (TTM operating cash flow ~-$102M; free cash flow ~-$107M).
Income Statement
18
Very Negative
Balance Sheet
22
Negative
Cash Flow
24
Negative
BreakdownMar 2026Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue361.85M798.89M734.67M631.67M1.06B
Gross Profit265.72M668.28M575.71M444.00M823.08M
EBITDA-333.66M173.71M24.10M-211.55M-393.21M
Net Income-257.13M-2.93M-63.26M-148.71M-189.36M
Balance Sheet
Total Assets987.38M1.49B1.50B1.66B2.07B
Cash, Cash Equivalents and Short-Term Investments32.90M40.92M90.81M16.46M84.36M
Total Debt672.59M527.97M543.05M557.42M696.29M
Total Liabilities992.70M1.03B1.04B1.07B1.18B
Stockholders Equity94.76M294.80M280.32M318.06M353.10M
Cash Flow
Free Cash Flow-130.19M-35.34M95.41M47.39M-318.81M
Operating Cash Flow-121.95M-21.61M109.14M60.90M-299.01M
Investing Cash Flow-8.25M3.81M-13.73M-13.51M-19.80M
Financing Cash Flow122.00M-32.03M-21.11M-115.05M259.09M

GoHealth Technical Analysis

Technical Analysis Sentiment
Negative
Last Price1.37
Price Trends
50DMA
0.68
Negative
100DMA
1.09
Negative
200DMA
2.17
Negative
Market Momentum
MACD
-0.08
Negative
RSI
35.87
Neutral
STOCH
61.71
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GOCOQ, the sentiment is Negative. The current price of 1.37 is above the 20-day moving average (MA) of 0.37, above the 50-day MA of 0.68, and below the 200-day MA of 2.17, indicating a bearish trend. The MACD of -0.08 indicates Negative momentum. The RSI at 35.87 is Neutral, neither overbought nor oversold. The STOCH value of 61.71 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GOCOQ.

GoHealth Risk Analysis

GoHealth disclosed 128 risk factors in its most recent earnings report. GoHealth reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

GoHealth Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
56
Neutral
$139.42M8.1715.28%10.29%
55
Neutral
$52.37M1.533.57%-4.28%-1.93%
51
Neutral
$11.67M-8.094.56%
39
Underperform
$11.72M-0.02-135.15%-81.69%-9884.70%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GOCOQ
GoHealth
0.37
-5.67
-93.92%
EHTH
Ehealth
1.69
-2.45
-59.18%
HUIZ
Huize Holding
1.19
-0.87
-42.23%
SLQT
SelectQuote
0.81
-1.57
-66.05%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jun 17, 2026